Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmj.l5221
PubMed Identifier: 31533922
Publication URI: http://europepmc.org/abstract/MED/31533922
Type: Journal Article/Review
Volume: 366
Parent Publication: BMJ (Clinical research ed.)
ISSN: 0959-8138